Zobrazeno 1 - 10
of 26
pro vyhledávání: '"Zhao-lin Chen"'
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-6 (2022)
Abstract Systemic lupus erythematosus (SLE) is a complex autoimmune disease characterized by the production of a diverse array of autoantibodies and the dysfunctional activation of the complement system. The specific association between the complemen
Externí odkaz:
https://doaj.org/article/3d03e35a049b45d1a035dec9e4950e9f
Autor:
Lei Zhang, Wen-Xu Chen, Ling-Li Li, Yu-Zhu Cao, Ya-Di Geng, Xiao-Jun Feng, Ai-Yun Wang, Zhao-Lin Chen, Yin Lu, Ai-Zong Shen
Publikováno v:
Frontiers in Pharmacology, Vol 11 (2020)
Background: Targeting inflammatory microenvironment is a promising anti-tumor strategy. Paeonol is a phenolic compound with effective anti-inflammatory and anti-tumor properties. However, the effects of paeonol on non-small cell carcinoma (NSCLC) hav
Externí odkaz:
https://doaj.org/article/ee9f898023c54b3ebfe3e868320bfc34
Autor:
Li Ma, Bo Qiu, Jun Zhang, Qi-Wen Li, Bin Wang, Xu-Hui Zhang, Meng-Yun Qiang, Zhao-Lin Chen, Su-Ping Guo, Hui Liu
Publikováno v:
Chinese Journal of Cancer, Vol 36, Iss 1, Pp 1-8 (2017)
Abstract Background Locoregional recurrence remains the challenge for long-term survival of non-small cell lung cancer (NSCLC) patients after radical surgery, and curative-intent radiotherapy could be a treatment choice. This study aimed to assess th
Externí odkaz:
https://doaj.org/article/0630b8c376c3495898323913fa993bee
Autor:
Li Ma, Guang-Yu Luo, Yu-Feng Ren, Bo Qiu, Hong Yang, Chun-Xia Xie, Song-Ran Liu, Shi-Liang Liu, Zhao-Lin Chen, Qun Li, Jian-Hua Fu, Meng-Zhong Liu, Yong-Hong Hu, Wen-Feng Ye, Hui Liu
Publikováno v:
Chinese Journal of Cancer, Vol 36, Iss 1, Pp 1-8 (2017)
Abstract Background Concurrent chemoradiotherapy (CCRT) significantly increases the survival rate of esophageal squamous cell carcinoma (ESCC) patients with malignant fistulae. Recent clinical evidence has shown the benefits of enteral nutrition for
Externí odkaz:
https://doaj.org/article/a3697381d75b489a92d9e1e5b0ca4d45
Autor:
Yin-cui Wu, Qi Yan, Si-qing Yue, Lin-xin Pan, Da-shuai Yang, Liang-song Tao, Ze-yuan Wei, Fan Rong, Cheng Qian, Meng-qi Han, Fu-cheng Zuo, Jun-fa Yang, Jia-jia Xu, Zheng-rong Shi, Jian Du, Zhao-lin Chen, Tao Xu
Publikováno v:
International Journal of Biological Sciences; 2024, Vol. 20 Issue 6, p2219-2335, 17p
Autor:
Fen-Ting Cheng, Ya-Di Geng, Yun-Xiao Liu, Xuan Nie, Xin-Ge Zhang, Zhao-Lin Chen, Li-Qin Tang, Long-Hai Wang, Ye-Zi You, Lei Zhang
Publikováno v:
Nanoscale Advances.
A functional nanoplatform Cu@P–B was constructed, which could release disulfiram prodrug and CuO2 to generate the poisonous copper complex and elevate ROS to kill tumor cells, providing a new perspective in cancer therapy.
Autor:
Fen-Ting Cheng, Ya-Di Geng, Yun-Xiao Liu, Xuan Nie, Xin-Ge Zhang, Zhao-Lin Chen, Li-Qin Tang, Long-Hai Wang, Ye-Zi You, Lei Zhang
Publikováno v:
Nanoscale Advances; 6/21/2023, Vol. 5 Issue 12, p3336-3347, 12p
Objective. Systemic lupus erythematosus (SLE) is a chronic autoimmune disease that is characterized by complement dysfunction and a wide range of autoantibody production. However, data about the relation between C3a and anti-ds DNA Ab in SLE are scar
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::284ca2e5cfab17664bd99ccdbf23ef16
https://doi.org/10.21203/rs.3.rs-962892/v1
https://doi.org/10.21203/rs.3.rs-962892/v1
Publikováno v:
Pharmacological research. 176
Hepatocellular carcinoma (HCC) is the fourth major contributor to cancer-related deaths worldwide, and patients mostly have poor prognosis. Although several drugs have been approved for the treatment of HCC, cisplatin (CDDP) is still applied in treat
Autor:
L. Ma, Hui Liu, WenFeng Ye, QiWen Li, Bo Qiu, GuangYu Luo, Bin Wang, SuPing Guo, Zhao-Lin Chen
Publikováno v:
Clinical Lung Cancer. 19:e211-e217
To investigate the relationship between malnutrition and the severity of radiation pneumonitis (RP) in patients with lung cancer with normal baseline pulmonary function and lungs' V20 35% treated by intensity-modulated radiation therapy (IMRT) and co